Dapsone
Who holds supplier records for Dapsone? 12 organisations hold a current record for Dapsone: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), Italy (2), Switzerland (1), United States (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dapsone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dapsone
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Dapsone expires 18 Nov 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dapsone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 33228, 35244 · latest filing Dec 2021
- ATUL LTDIndiaCEPActive DMF 17781 · latest filing Oct 2004
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 35342 · latest filing Oct 2020
- EXTROVIS AGSwitzerlandCEPActive DMF 33630 · latest filing Mar 2019
- MEDILUX LABORATORIES PVT LTDIndiaCEP Company GMP cert on recordActive DMF 35786, 38378 · latest filing Jun 2023
- CHONGQING HUAPONT PHARMACEUTICAL CO LTDActive DMF 38483 · latest filing Jul 2023
- Dipharma Francis SrlItaly Company GMP cert on recordActive DMF 31521 · latest filing Jun 2017
- LUNDBECK PHARMACEUTICALS ITALY SPAItaly Company GMP cert on recordActive DMF 15065 · latest filing Sept 2000
- NOVITIUM PHARMA LLCUnited StatesActive DMF 27678 · latest filing Dec 2013
- Sai Life Sciences LimitedIndiaActive DMF 27701 · latest filing Nov 2013
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 29999 · latest filing Mar 2016
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Dapsone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ATUL LIMITED Valsad | IN | CEP 2015-177 - Rev 01 Dapsone | Jul 2026 | — |
| EXTROVIS AG Baar | CH | CEP 2022-379 - Rev 01 Dapsone | May 2026 | — |
| NURAY CHEMICALS PRIVATE LIMITED Thiruvallur | IN | CEP 2023-396 - Rev 00 Dapsone | Sept 2025 | — |
| MEDILUX LABORATORIES PRIVATE LIMITED Pithampur | IN | CEP 2023-195 - Rev 00 Dapsone | Jun 2025 | Inspected Nov 2025 Germany |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2020-358 - Rev 01 Dapsone | Jul 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Dapsone are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- REGIS TECHNOLOGIES INCInactive DMF 25089 · filed Jun 2011
- JACOBUS PHARMACEUTICAL COInactive DMF 7413 · filed Mar 1988
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (29 listed products contain Dapsone). The latest listed patent expires 18 Nov 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Dapsone is an antimicrobial compound used primarily to treat leprosy and dermatitis herpetiformis. It acts as a bacteriostatic agent by inhibiting bacterial synthesis of dihydrofolic acid.
Chemical identity
- IUPAC name
- 4-(4-aminophenyl)sulfonylaniline
- Canonical SMILES
- C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
- InChIKey
- MQJKPEGWNLWLTK-UHFFFAOYSA-N
- Synonyms
- Aczone API, dapsone, 4,4'-Sulfonyldianiline, Diaphenylsulfone, 4,4'-Diaminodiphenyl sulfone, Dapson, 4,4'-Diaminodiphenylsulfone, DADPS, Diphenasone, Novophone, Disulone, Sulfona
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Sulfone
- Chemical structure
- Sulfones
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dapsone?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Dapsone: Macleods Pharmaceuticals Ltd. (India), ATUL LTD (India), COHANCE LIFESCIENCES LTD (India), EXTROVIS AG (Switzerland), MEDILUX LABORATORIES PVT LTD (India), CHONGQING HUAPONT PHARMACEUTICAL CO LTD, Dipharma Francis Srl (Italy) and LUNDBECK PHARMACEUTICALS ITALY SPA (Italy), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dapsone Drug Master Files are active?
Macleods Pharmaceuticals Ltd. (DMF 33228, 35244), ATUL LTD (DMF 17781), COHANCE LIFESCIENCES LTD (DMF 35342), EXTROVIS AG (DMF 33630), MEDILUX LABORATORIES PVT LTD (DMF 35786, 38378), CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 38483), Dipharma Francis Srl (DMF 31521) and LUNDBECK PHARMACEUTICALS ITALY SPA (DMF 15065) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dapsone records mean?
2 organisations have only inactive Type II DMFs for Dapsone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dapsone have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Dapsone on the EDQM register, including ATUL LIMITED Valsad (IN), EXTROVIS AG Baar (CH), NURAY CHEMICALS PRIVATE LIMITED Thiruvallur (IN), MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN) and COHANCE LIFESCIENCES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Dapsone?
Yes. The latest patent listed for an approved US product containing Dapsone expires 18 Nov 2033, across 29 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Dapsone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dapsone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.